|
WO2017077062A1
|
|
A peptide derived from human neutrophile peptide 1
|
|
WO2017064222A1
|
|
Cxcr6-transduced t cells for targeted tumor therapy
|
|
DE102016010081A1
|
|
An efficient synthesis for benzoperylene derivatives. Improvement of the Diels-Alder-Clar reaction
|
|
EP3275865A1
|
|
Amide-based hole-transporting or hole-injecting materials
|
|
WO2016184652A1
|
|
Methods for producing metalated organic compounds
|
|
EP3187180A1
|
|
Adenosylhomocysteinase binding substances for medical use
|
|
EP3176252A1
|
|
A system and method for determining a force applied to or generated by a cell or tissue culture
|
|
EP3168224A1
|
|
Organozinc composition
|
|
EP3165536A1
|
|
Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition
|
|
EP3159332A1
|
|
5,5'-bis(2,4,6-trinitrophenyl)-2,2'-bi(1,3,4-oxadiazole) and bis(2,4,6-trinitrobenzoyl)oxalohydrazide
|
|
EP3156801A1
|
|
Sicam-1 as biomarker for pain and pain intensity
|
|
EP3146981A1
|
|
Covalently attached azobenzene switches and their uses for the optical control of target proteins
|
|
EP3124473A1
|
|
Bis(3,4,5-trinitropyrazolyl)methane and bis(3,5-dinitro-4-aminopyrazolyl)methane as explosives
|
|
EP3120700A1
|
|
Microinjection into a cell's nucleus following somatic cell nuclear transfer
|
|
DE102015009297A1
|
|
Process for the preparation of 3,3'-dinitro-5,5'-bis (1H-1,2,4-triazole)
|
|
EP3112375A1
|
|
Antigenic peptides for the diagnosis, therapy monitoring and/or treatment of psoriasis vulgaris
|
|
DE102014019551A1
|
|
Terminal substituted oligothiophenes
|
|
US2016091429A1
|
|
System and method for stimulated raman spectroscopy
|
|
EP2007416A2
|
|
Paratyroid hormone (pth) for use in the treatment of ischemia
|
